Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current Pharmaceutical Biotechnology|April 8, 2011
Tumor vasculature targeting through NGR peptide-based drug delivery systemsAngelo Corti, Flavio CurnisMethods in Molecular Medicine|April 6, 2004
Production and characterization of recombinant human and murine TNFFlavio Curnis, Angelo CortiJournal of Cell Science|February 2, 2011
Isoaspartate-dependent molecular switches for integrin-ligand recognitionAngelo Corti, Flavio CurnisThe Journal of Clinical Investigation|August 22, 2002
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alterationFlavio Curnis, Angelina Sacchi, Angelo CortiPharmaceutics|December 23, 2022
Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived PeptidesAngelo Corti, Giulia Anderluzzi, Flavio CurnisMethods in Molecular Biology (Clifton, N.J.)|October 7, 2022
Quantification of Chromogranin A and Its Fragments in Biological FluidsFlavio Curnis, Barbara Colombo, Angelo CortiBlood|June 25, 2008
The neovasculature homing motif NGR: more than meets the eyeAngelo Corti, Flavio Curnis, Wadih Arap, et al.Cancer Research|October 7, 2004
Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicinAngelina Sacchi, Anna Gasparri, Flavio Curnis, et al.Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 8, 2013
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF exampleAngelo Corti, Flavio Curnis, Gilda Rossoni, et al.Pageof 7